Cargando…
EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3)
SIMPLE SUMMARY: The Epstein–Barr virus (EBV) is a commonly occurring virus, infecting more than 90% of the world population, often early in life. However, only a minority of individuals develop EBV-driven diseases at some point in their lifetime. EBV is associated with several neoplasms including ep...
Autores principales: | , , , , , , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656853/ https://www.ncbi.nlm.nih.gov/pubmed/34885131 http://dx.doi.org/10.3390/cancers13236021 |
_version_ | 1784612381470490624 |
---|---|
author | Zanelli, Magda Sanguedolce, Francesca Palicelli, Andrea Zizzo, Maurizio Martino, Giovanni Caprera, Cecilia Fragliasso, Valentina Soriano, Alessandra Gozzi, Fabrizio Cimino, Luca Masia, Francesco Moretti, Marina Foroni, Moira De Marco, Loredana Pellegrini, David De Raeve, Hendrik Ricci, Stefano Tamagnini, Ione Tafuni, Alessandro Cavazza, Alberto Merli, Francesco Pileri, Stefano A. Ascani, Stefano |
author_facet | Zanelli, Magda Sanguedolce, Francesca Palicelli, Andrea Zizzo, Maurizio Martino, Giovanni Caprera, Cecilia Fragliasso, Valentina Soriano, Alessandra Gozzi, Fabrizio Cimino, Luca Masia, Francesco Moretti, Marina Foroni, Moira De Marco, Loredana Pellegrini, David De Raeve, Hendrik Ricci, Stefano Tamagnini, Ione Tafuni, Alessandro Cavazza, Alberto Merli, Francesco Pileri, Stefano A. Ascani, Stefano |
author_sort | Zanelli, Magda |
collection | PubMed |
description | SIMPLE SUMMARY: The Epstein–Barr virus (EBV) is a commonly occurring virus, infecting more than 90% of the world population, often early in life. However, only a minority of individuals develop EBV-driven diseases at some point in their lifetime. EBV is associated with several neoplasms including epithelial, mesenchymal and lymphoid tumors. EBV-driven lymphoid proliferations encompass a wide spectrum of diseases with different biological behaviors, developing frequently, although not always, in conditions of immunosuppression. The diagnosis is often complicated and requires a strict combination of clinical, pathological and molecular findings. The aim of this review, divided into three parts, is to provide an update on EBV-driven lymphoproliferative disorders arising in the gastrointestinal tract. In this review, we discuss the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders. ABSTRACT: EBV is the first known oncogenic virus involved in the development of several tumors. The majority of the global population are infected with the virus early in life and the virus persists throughout life, in a latent stage, and usually within B lymphocytes. Despite the worldwide diffusion of EBV infection, EBV-associated diseases develop in only in a small subset of individuals often when conditions of immunosuppression disrupt the balance between the infection and host immune system. EBV-driven lymphoid proliferations are either of B-cell or T/NK-cell origin, and range from disorders with an indolent behavior to aggressive lymphomas. In this review, which is divided in three parts, we provide an update of EBV-associated lymphoid disorders developing in the gastrointestinal tract, often representing a challenging diagnostic and therapeutic issue. Our aim is to provide a practical diagnostic approach to clinicians and pathologists who face this complex spectrum of disorders in their daily practice. In this part of the review, the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders are discussed. |
format | Online Article Text |
id | pubmed-8656853 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-86568532021-12-10 EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) Zanelli, Magda Sanguedolce, Francesca Palicelli, Andrea Zizzo, Maurizio Martino, Giovanni Caprera, Cecilia Fragliasso, Valentina Soriano, Alessandra Gozzi, Fabrizio Cimino, Luca Masia, Francesco Moretti, Marina Foroni, Moira De Marco, Loredana Pellegrini, David De Raeve, Hendrik Ricci, Stefano Tamagnini, Ione Tafuni, Alessandro Cavazza, Alberto Merli, Francesco Pileri, Stefano A. Ascani, Stefano Cancers (Basel) Review SIMPLE SUMMARY: The Epstein–Barr virus (EBV) is a commonly occurring virus, infecting more than 90% of the world population, often early in life. However, only a minority of individuals develop EBV-driven diseases at some point in their lifetime. EBV is associated with several neoplasms including epithelial, mesenchymal and lymphoid tumors. EBV-driven lymphoid proliferations encompass a wide spectrum of diseases with different biological behaviors, developing frequently, although not always, in conditions of immunosuppression. The diagnosis is often complicated and requires a strict combination of clinical, pathological and molecular findings. The aim of this review, divided into three parts, is to provide an update on EBV-driven lymphoproliferative disorders arising in the gastrointestinal tract. In this review, we discuss the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders. ABSTRACT: EBV is the first known oncogenic virus involved in the development of several tumors. The majority of the global population are infected with the virus early in life and the virus persists throughout life, in a latent stage, and usually within B lymphocytes. Despite the worldwide diffusion of EBV infection, EBV-associated diseases develop in only in a small subset of individuals often when conditions of immunosuppression disrupt the balance between the infection and host immune system. EBV-driven lymphoid proliferations are either of B-cell or T/NK-cell origin, and range from disorders with an indolent behavior to aggressive lymphomas. In this review, which is divided in three parts, we provide an update of EBV-associated lymphoid disorders developing in the gastrointestinal tract, often representing a challenging diagnostic and therapeutic issue. Our aim is to provide a practical diagnostic approach to clinicians and pathologists who face this complex spectrum of disorders in their daily practice. In this part of the review, the chronic active EBV infection of T-cell and NK-cell type, its systemic form; extranodal NK/T-cell lymphoma, nasal type and post-transplant lymphoproliferative disorders are discussed. MDPI 2021-11-30 /pmc/articles/PMC8656853/ /pubmed/34885131 http://dx.doi.org/10.3390/cancers13236021 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Zanelli, Magda Sanguedolce, Francesca Palicelli, Andrea Zizzo, Maurizio Martino, Giovanni Caprera, Cecilia Fragliasso, Valentina Soriano, Alessandra Gozzi, Fabrizio Cimino, Luca Masia, Francesco Moretti, Marina Foroni, Moira De Marco, Loredana Pellegrini, David De Raeve, Hendrik Ricci, Stefano Tamagnini, Ione Tafuni, Alessandro Cavazza, Alberto Merli, Francesco Pileri, Stefano A. Ascani, Stefano EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) |
title | EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) |
title_full | EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) |
title_fullStr | EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) |
title_full_unstemmed | EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) |
title_short | EBV-Driven Lymphoproliferative Disorders and Lymphomas of the Gastrointestinal Tract: A Spectrum of Entities with a Common Denominator (Part 3) |
title_sort | ebv-driven lymphoproliferative disorders and lymphomas of the gastrointestinal tract: a spectrum of entities with a common denominator (part 3) |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8656853/ https://www.ncbi.nlm.nih.gov/pubmed/34885131 http://dx.doi.org/10.3390/cancers13236021 |
work_keys_str_mv | AT zanellimagda ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT sanguedolcefrancesca ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT palicelliandrea ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT zizzomaurizio ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT martinogiovanni ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT capreracecilia ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT fragliassovalentina ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT sorianoalessandra ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT gozzifabrizio ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT ciminoluca ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT masiafrancesco ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT morettimarina ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT foronimoira ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT demarcoloredana ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT pellegrinidavid ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT deraevehendrik ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT riccistefano ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT tamagniniione ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT tafunialessandro ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT cavazzaalberto ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT merlifrancesco ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT pileristefanoa ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 AT ascanistefano ebvdrivenlymphoproliferativedisordersandlymphomasofthegastrointestinaltractaspectrumofentitieswithacommondenominatorpart3 |